TLSI NASDAQ
TriSalus Life Sciences, Inc.
1W: +3.8%
1M: -13.4%
3M: -13.2%
YTD: -37.7%
1Y: -25.8%
3Y: -21.6%
5Y: -61.7%
$3.80
+0.18 (+4.97%)
Weekly Expected Move ±6.1%
$3
$3
$4
$4
$4
Credit Risk of going bust: higher than 75% of companies Debt: 12.8% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.09 (down 98%), TriSalus Life Sciences, Inc. would be worth roughly what it owes.
Total debt $34.4M against a stock market value of $234.0M.
Distance to default 3.04 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $16.5M (short-term plus half of long-term), stock volatility 85.6%; Altman Z -4.60. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.09 (down 98%), TriSalus Life Sciences, Inc. would be worth roughly what it owes.
Total debt $34.4M against a stock market value of $234.0M.
Distance to default 3.04 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $16.5M (short-term plus half of long-term), stock volatility 85.6%; Altman Z -4.60. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships0
As Filer
counterparties named
6
As Counterparty
mentioned by others
2022-11-14
Earliest Filing
2023-06-08
Latest Filing
Mentioned As Counterparty
6 mentionsOther companies that named TLSI in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| TLSIW MedTech Acquisition Corp | acquirer | Target company in the proposed business combination merger. | 2023-06-08 | View |
| TLSIW MedTech Acquisition Corp | acquirer | Target company in the proposed business combination with MedTech Acquisition Corporation. | 2023-05-15 | View |
| TLSIW MedTech Acquisition Corp | acquirer | Target company in the proposed merger with MedTech Acquisition Corporation | 2023-04-05 | View |
| TLSIW MedTech Acquisition Corp | acquirer | Target company in the proposed business combination with MTAC | 2023-03-08 | View |
| TLSIW MedTech Acquisition Corp | acquirer | Target company in the business combination merger agreement. | 2022-12-19 | View |
| TLSIW MedTech Acquisition Corp | acquirer | Target company in the business combination with MTAC | 2022-11-14 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-22 | Other Events; Exhibits | View | |
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-05-14 | Shareholder Vote | View | |
| 2026-05-12 | Earnings Release; Exhibits | View | |
| 2026-04-29 | Officer/Director Change | View | |
| 2026-04-07 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-03-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-02-20 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2026-02-09 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-10-01 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-29 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-08-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-24 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2025-06-23 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-16 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-30 | Departure/Election of Directors; Appointment of Officers; Other Events; Financial Statements and Exh | View | |
| 2025-05-15 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-30 | Entry into Material Definitive Agreement; Results of Operations and Financial Condition; Unregistere | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR